Drug details
Novoseven (coagulation factor viia (recombinant))
type of Coagulation Factors
NovoSeven (coagulation factor Vlla recombinant) is a blood coagulant compound. NovoSeven is prescribed for the prevention and treatment of bleeding in hemophilia A or B, patients with inhibitors to Factor VIII or Factor IX, and acquired hemophilia.
This drug may have the following side effects:
- headache,
- dizziness,
- fever,
- nausea, or
- injection site reactions (pain, redness, or irritation),
- vomiting.
The following drugs are related to Novoseven, either as a replacement or used together:
- Advate ([antihemophilic factor (recombinant), plasma/albumin-free method] for intravenous injection)
- Adynovate (antihemophilic factor (recombinant), pegylated for injection)
- Alprolix ([coagulation factor ix (recombinant), fc fusion protein], lyophilized powder for solution for intravenous injection)
- Altuviiio (antihemophilic factor (recombinant), fc-vwf-xten fusion protein-ehtl)
- Novoeight (antihemophilic factor (recombinant) lyophilized powder for intravenous injection)
- Jivi (antihemophilic factor (recombinant), pegylated-aucl for injection)
- Nuwiq (antihemophilic factor recombinant intravenous infusion)
- Humate-P (antihemophilic factor/von willebrand factor complex (human) injection)
- Bebulin VH (factor ix complex intravenous administration)
- Coagadex (coagulation factor x lyophilized powder)
- Idelvion (coagulation factor ix (recombinant) albumin fusion protein lyophilized powder intravenous injection)
- Rixubis (coagulation factor ix (recombinant) for intramuscular injection)
- Sevenfact (coagulation factor viia (recombinant)-jncw for injection)
- Esperoct ([antihemophilic factor (recombinant), glycopegylated-exei] injection)
- Profilnine (factor ix complex intravenous administration)
- Octaplas (pooled plasma (human) solvent/detergent)